Verona Pharma PLC Investor & Analyst R&D Forum Transcript
Good morning. Welcome to the Verona Investor and R&D Analyst Meeting this morning. My name is Brian Leaker. I'm a physician and my involvement with Verona or, I should say, this particular compound goes back over 20 years, but more of that later. And I'll be chairing the distinguished panel shortly.
But firstly, let me invite Jan-Anders Karlsson, who is the CEO of Verona, to introduce the meeting and to tell you about what an exciting prospect he has in his grasp. Jan?
Thank you very much. So good morning, and welcome to this Investor and Analyst R&D forum. We'd like to take this opportunity to talk about one of the most common respiratory diseases in the world. So a lot of patients suffering. We'll talk about it in much more detail over the next couple of hours. And of course, we are also looking forward to presentations around what we believe is a very promising compound
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
